User profiles for Robert A. Wise

Robert Wise

Johns Hopkins University
Verified email at jhmi.edu
Cited by 75544

[HTML][HTML] Tuberculosis associated with infliximab, a tumor necrosis factor α–neutralizing agent

J Keane, S Gershon, RP Wise… - … England Journal of …, 2001 - Mass Medical Soc
Background Infliximab is a humanized antibody against tumor necrosis factor α (TNF-α) that
is used in the treatment of Crohn's disease and rheumatoid arthritis. Approximately 147,000 …

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study

…, GR Owens, PD Scanlon, DP Tashkin, RA Wise… - Jama, 1994 - jamanetwork.com
Objective. —To determine whether a program incorporating smoking intervention and use
of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 …

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

NR Anthonisen, MA Skeans, RA Wise… - Annals of internal …, 2005 - acpjournals.org
Background: Randomized clinical trials have not yet demonstrated the mortality benefit of
smoking cessation. Objective: To assess the long-term effect on mortality of a randomly applied …

A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars

TJ Török, RV Tauxe, RP Wise, JR Livengood… - Jama, 1997 - jamanetwork.com
Context. —This large outbreak of foodborne disease highlights the challenge of investigating
outbreaks caused by intentional contamination and demonstrates the vulnerability of self-…

American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

…, D Valeyre, A Wells, RA Wise… - … of respiratory and …, 2002 - mayoclinic.elsevierpure.com
Despite the considerable progress in the classification of the idiopathic interstitial pneumonias
(IIPs), the lack of an international standard has resulted in variable and confusing …

[HTML][HTML] Once-daily single-inhaler triple versus dual therapy in patients with COPD

…, D Singh, M Tabberer, RA Wise… - … England Journal of …, 2018 - Mass Medical Soc
Background The benefits of triple therapy for chronic obstructive pulmonary disease (COPD)
with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-…

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

KA O'Connell, JJ Wood, RP Wise, JN Lozier, MM Braun - Jama, 2006 - jamanetwork.com
ContextThe US Food and Drug Administration (FDA) licensed recombinant human coagulation
factor VIIa (rFVIIa) on March 25, 1999, for bleeding in patients with hemophilia A or B and …

The ultrastructure of chilling stress

HA Kratsch, RR Wise - Plant, Cell & Environment, 2000 - Wiley Online Library
Chilling injury to crop plants was first described 70 years ago and has been systematically
investigated with electron microscopy since the late 1960s. Chloroplasts are the first and most …

Chilling-enhanced photooxidation: evidence for the role of singlet oxygen and superoxide in the breakdown of pigments and endogenous antioxidants

RR Wise, AW Naylor - Plant Physiology, 1987 - academic.oup.com
Chilling temperatures (5C) and high irradiance (1000 microeinsteins per square meter per
second) were used to induce photooxidation in detached leaves of cucumber (Cucumis …

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

…, M John, JA Anderson, M Zvarich, RA Wise - Thorax, 2007 - thorax.bmj.com
Background: TORCH (Towards a Revolution in COPD Health) is an international multicentre,
randomised, placebo-controlled clinical trial of inhaled fluticasone propionate/salmeterol …